Cargando…
Genome-based therapeutic interventions for β-type hemoglobinopathies
For decades, various strategies have been proposed to solve the enigma of hemoglobinopathies, especially severe cases. However, most of them seem to be lagging in terms of effectiveness and safety. So far, the most prevalent and promising treatment options for patients with β-types hemoglobinopathie...
Autores principales: | Karamperis, Kariofyllis, Tsoumpeli, Maria T., Kounelis, Fotios, Koromina, Maria, Mitropoulou, Christina, Moutinho, Catia, Patrinos, George P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178887/ https://www.ncbi.nlm.nih.gov/pubmed/34090531 http://dx.doi.org/10.1186/s40246-021-00329-0 |
Ejemplares similares
-
Adoption of Pharmacogenomic Testing: A Marketing Perspective
por: Koufaki, Margarita-Ioanna, et al.
Publicado: (2021) -
Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study
por: Koufaki, Margarita-Ioanna, et al.
Publicado: (2023) -
Systematic review of economic evaluation studies in psychiatric pharmacogenomics
por: Mitropoulou, C., et al.
Publicado: (2021) -
Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics
por: Koromina, Maria, et al.
Publicado: (2020) -
β-Hemoglobinopathies: The Test Bench for Genome Editing-Based Therapeutic Strategies
por: Barbarani, Gloria, et al.
Publicado: (2020)